Heart Failure With Preserved Ejection Fraction: Prevention and Management

American Journal of Lifestyle Medicine
Lindsey CiliaWen-Chih Wu

Abstract

Heart failure with preserved ejection fraction (HFpEF) is a complex clinical syndrome that constitutes nearly half of all heart failure cases. Because of lack of effective pharmacological targets to improve outcomes, the emphasis of the management and prevention of HFpEF should be through control of risk factors. This review will use the framework proposed by the American Heart Association on 7 simple measures ("Life's Simple 7") that involves diet and lifestyle changes to achieve ideal cardiovascular health. These 7 measures include (1) smoking, (2) obesity, (3) exercise, (4) diet, (5) blood pressure, (6) cholesterol, and (7) glucose control, which can help control the most common comorbidities and risk factors associated with HFpEF, such as hypertension, diabetes, and obesity. Therefore, application of these 7 simple measures would be a patient-centered and cost-effective way of prevention and management of HFpEF.

References

Mar 1, 1996·Diabetes Care·D GiuglianoG Paolisso
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·Y T ZhouR H Unger
May 10, 2001·Journal of the American College of Cardiology·N SuskinS Yusuf
Jan 31, 2003·Cardiovascular Diabetology·Christophe BautersPascal de Groote
Feb 21, 2003·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Lidia S SzczepaniakRonald G Victor
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Dec 10, 2003·Journal of the American College of Cardiology·Mathias RauchhausStefan D Anker
Feb 28, 2004·Diabetes Care·Alain G BertoniDavid C Goff
Aug 28, 2004·The Medical Clinics of North America·Satish KenchaiahRamachandran S Vasan
Mar 28, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Anne-Maj SamuelssonAgneta Holmäng
Jul 21, 2006·The New England Journal of Medicine·Theophilus E OwanMargaret M Redfield
Sep 12, 2006·European Heart Journal·John G F ClelandUNKNOWN PEP-CHF Investigators
Oct 14, 2006·Current Treatment Options in Cardiovascular Medicine·William L Isley
Dec 13, 2006·American Heart Journal·Nasim AfsarmaneshGregg C Fonarow
Sep 13, 2007·JAMA : the Journal of the American Medical Association·A Michael LincoffSteven E Nissen
Sep 22, 2007·Journal of Hypertension·Alberto ZanchettiGiuseppe Vargiu
Nov 7, 2007·The New England Journal of Medicine·John KjekshusUNKNOWN CORONA Group
Dec 13, 2007·JAMA : the Journal of the American Medical Association·Lorraine L LipscombeDavid A Alter
Nov 13, 2008·Circulation·Hutan AshrafianThanos Athanasiou
Nov 13, 2008·The New England Journal of Medicine·Barry M MassieUNKNOWN I-PRESERVE Investigators
Nov 27, 2008·American Heart Journal·Tamara B HorwichGregg C Fonarow
Apr 9, 2009·JAMA : the Journal of the American Medical Association·Christopher M O'ConnorUNKNOWN HF-ACTION Investigators
Apr 9, 2009·JAMA : the Journal of the American Medical Association·Kathryn E FlynnUNKNOWN HF-ACTION Investigators
Aug 15, 2009·Journal of the American College of Cardiology·Oliver J RiderStefan Neubauer
Dec 10, 2009·Hypertension·Scott D SolomonUNKNOWN Exforge Intensive Control of Hypertension to Evaluate Efficacy in Diastolic Dysfunction Investigators
Jan 22, 2010·Circulation·Donald M Lloyd-JonesUNKNOWN American Heart Association Strategic Planning Task Force and Statistics Committee
Jan 22, 2010·The Cochrane Database of Systematic Reviews·Shelley R SalpeterEdwin E Salpeter Posthumous
May 4, 2010·The Journal of Clinical Hypertension·Massimo VolpeHelmut Drexler
Jun 24, 2010·The American Journal of Medicine·Mohamed F AlgahimHeinrich Taegtmeyer
Oct 19, 2010·Circulation. Heart Failure·David AguilarAnita Deswal

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.